Cargando…
Tumour response evaluation with fluorodeoxyglucose positron emission tomography: research technique or clinical tool?
The evaluation of treatment response is an established role for imaging in oncologic research and clinical practice. In early phase trials, imaging response criteria are used to determine the presence and magnitude of the drug effect on tumour to aid decisions concerning progress to late phase trial...
Autores principales: | Anderson, H., Singh, N., Miles, K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
e-Med
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967135/ https://www.ncbi.nlm.nih.gov/pubmed/20880775 http://dx.doi.org/10.1102/1470-7330.2010.9088 |
Ejemplares similares
-
Promises and challenges of positron emission tomography for assessment of sarcoma in daily clinical practice
por: van de Luijtgaarden, A.C.M., et al.
Publicado: (2008) -
Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography in Disseminated Cryptococcosis
por: Tripathy, Sarthak, et al.
Publicado: (2017) -
Fluorodeoxyglucose positron emission tomography in pyrexia of unknown origin
por: Angamuthu, Meivel, et al.
Publicado: (2020) -
Neurolymphomatosis detected by (18)F‐fluorodeoxyglucose‐positron emission tomography
por: Hori, Yoshikazu, et al.
Publicado: (2020) -
Fluorodeoxyglucose Positron Emission Tomography Imaging in Pneumocystis jiroveci Pneumonia
por: Rathore, Hemant, et al.
Publicado: (2022)